AMED SCARDA「ワクチン開発のための世界トップレベル研究開発拠点の形成事業」合同シンポジウム

*Atsushi Sasaki^1,2,3, Masahiro Kiuchi², Hiroyuki Yagyu², Takahiro Arano^2,3, Toshinori Nakayama⁴, Takuji Suzuki³, Kiyoshi Hirahara² (1. Chiba University, Synergy Institute for Futuristic Mucosal Vaccine (Japan), 2. Department of Immunology, Graduate School of Medicine, Chiba University (Japan), 3. Department of Respirology, Graduate School of Medicine, Chiba University (Japan), 4. Chiba University (Japan))

*Takahisa Hishiya^1,2, Masahiro Kiuchi¹, Seiji Ohtori², Kiyoshi Hirahara¹ (1. Department of Immunology, Chiba University (Japan), 2. Department of Orthopaedic Surgery, Chiba University (Japan))

*Hiromitsu Tazawa¹, Yuki Furuya¹, Osamu Kikuchi^1,2, kazumi Sawakami⁴, Hidegi Tajima⁴, Manabu Mutou^1,3 (1. Clinical Bioresource Center/Kyoto University Hospital (Japan), 2. Center for Cancer Immunotherapy and Immunobiology/CCII (Japan), 3. Clinical Oncology, Kyoto University Hospital (Japan), 4. Precision System Science Inc. (Japan))

*Shohei Asami¹, Tamotsu Kato¹, Yumiko Nakanishi¹, Ayumi Ito¹, Hiroshi Ohno¹ (1. RIKEN Center for Integrative Medical Sciences Laboratory for Intestinal Ecosystem (Japan))

*Kohei Kometani¹, Takaaki Yorimitsu^1,2, Norihide Jo^1,3, Yoko Hamazaki^1,4,5 (1. Center for iPS Cell Research and Application (CiRA), Kyoto University (Japan), 2. Department of Human Health Sciences, Graduate School of Medicine, Kyoto University (Japan), 3. Alliance Laboratory for Advanced Medical Research, Graduate School of Medicine, Kyoto University (Japan), 4. Laboratory of Immunobiology, Graduate School of Medicine, Kyoto University (Japan), 5. Kyoto University Immunomonitoring Center (KIC) (Japan))

*Hao Zhou^1,2, Kazutaka Katoh^1,2, Daron M. Standley^1,2 (1. Research Institute for Microbial Diseases, Osaka University (Japan), 2. Immunology Frontier Research Center, Osaka University (Japan))

*Tsutomu Tanaka¹, Torsten B Meissner^2,3, Saptha Vijayan⁴, Kyoung-Hee Lee^2,3, Yuen-Joyce Liu², Isaac Downs⁴, Tabasum Sidiq⁴, Jason Yeung⁴, Chi Zhang², Peter van den Elsen^5,6, Koichi S Kobayashi^1,4 (1. The Institute for Vaccine Research and Development, Hokkaido University (Japan), 2. Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute (United States of America), 3. Department of Microbiology and Immunobiology, Division of Immunology, Harvard Medical School (United States of America), 4. Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center (United States of America), 5. Department of Immunohematology and Blood Transfusion, Leiden University Medical Center (Netherlands), 6. Department of Pathology, VU University Medical Center, Amsterdam (Netherlands))

*Zufang Wu¹, Yusuke Kasuga^1,3, Tsutomu Tanaka^1,3, Koichi Kobayashi^1,2,3 (1. Department of Immunology, Hokkaido University Graduate School of Medicine (Japan), 2. Department of Microbial Pathogenesis and Immunology, Texas A&M University (United States of America), 3. Hokkaido University Institute for Vaccine Research and Development (Japan))

*Shunsuke Mori¹, Hisashi Arase^1,2,3 (1. World Premier International Immunology Frontier Research Centre, Osaka University (Japan), 2. Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University (Japan), 3. Center for advanced modalities and DDS, Osaka University (Japan))

*Hugo Angel Sato¹, Kazuhiko Maeda^1,2, Youdiil Ophinni^1,3, Arthur Millius^1,4, Shizuo Akira^1,2,5 (1. Laboratory of Host Defense, WPI Immunology Frontier Research Center (WPI-IFReC), Osaka University, Osaka, Japan (Japan), 2. Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan (Japan), 3. Hakubi Center for Advanced Research, Department of Environmental Coexistence, Center for Southeast Asian Studies, Kyoto University (Japan), 4. Laboratory of Systems Immunology, WPI Immunology Frontier Research Center (WPI-IFReC), Osaka University, Osaka, Japan (Japan), 5. Center for Advanced Modalities and Drug Delivery System (CAMaD), Osaka University (Japan))

*Yuka Kobayashi¹, Takeshi Watanabe¹, Hiroshi Kawamoto¹ (1. Institute for Life and Medical Sciences, Kyoto University (Japan))

*Hayato Kasai^1,2, Yuki Hosono^1,2, Noriyuki Tomiyasu³, Yoshihiro Izumi³, Eri Ishikawa^1,2, Masatomo Takahashi³, Takeshi Bamba⁴, Sho Yamasaki^1,2,4 (1. Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University (Japan), 2. Laboratory of Molecular Immunology, Immunology Frontier Research Center (IFReC), Osaka University (Japan), 3. Division of Metabolomics, Medical Institute of Bioregulation, Kyushu University (Japan), 4. Center for Infectious Disease Education and Research (CiDER), Osaka University (Japan))

*Genta FURUYA¹, Taiga KIMISHIMA¹, Satoru NAGATOISHI², Rae MAEDA³, Keishu TAKAHASHI¹, Ryutaro TAMANO¹, Tomoya OHNO¹, Tomoki YOSHIHARA⁴, Kengo SASAKI¹, Naoki MORITA¹, Gao PENG¹, Fabian EISENSTEIN⁷, Hirofumi KOSUGE², Masumi SHIRAKAWA⁶, Hiroyuki ARAI⁸, Radostin DANEV⁷, Masahide KIKKAWA⁷, Shinsuke SANDO⁶, Naoshi DOHMAE⁵, Toshio HAKOSHIMA⁴, Yuki SUGIURA³, Kohei TSUMOTO², Reiko SHINKURA¹ (1. Laboratory of Immunology and Infection Control, Institute for Quantitative Biosciences, The University of Tokyo (Japan), 2. Department of Bioengineering, School of Engineering, The University of Tokyo (Japan), 3. Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine (Japan), 4. Division of Biological Science, Graduate School of Science and Technology, Nara Institute of Science and Technology (Japan), 5. Biomolecular Characterization Unit, RIKEN Center for Sustainable Resource Science (Japan), 6. Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo (Japan), 7. Department of Cell Biology and Anatomy, Graduate School of Medicine, The University of Tokyo (Japan), 8. Department of Biotechnology, Graduate School of Agricultural and Life Sciences, The University of Tokyo (Japan))

*Kotaro Tanaka¹, Keiko Yasuda^1,2, Junichi Aoki^1,3, Shintaro Shichinohe⁴, Chikako Ono^5,6,7, Alexis Vandenbon⁸, Daiya Ohara⁹, Yukiko Muramoto¹⁰, Songling Li¹¹, Daisuke Motooka¹², Hitomi Watanabe⁹, Keiji Hirota⁹, Gen Kondoh⁹, Takeshi Noda¹⁰, Daron M. Standley¹¹, Yuzuru Ikehara¹³, Seiji Okada³, Tokiko Watanabe^4,6,7, Yoshiharu Matsuura^5,6,7, Osamu Takeuchi¹ (1. Department of Medical Chemistry, Graduate School of Medicine, Kyoto University (Japan), 2. Department of Immunology, Nagoya City University Graduate School of Medical Sciences (Japan), 3. Department of Orthopaedic Surgery, Graduate School of Medicine, Osaka University (Japan), 4. Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University (Japan), 5. Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University (Japan), 6. Center for Infectious Disease Education and Research, Osaka University (Japan), 7. Center for Advanced Modalities and DDS, Osaka University (Japan), 8. Laboratory of Tissue Homeostasis, Institute for Life and Medical Sciences, Kyoto University (Japan), 9. Laboratory of Integrative Biological Science, Institute for Life and Medical Sciences, Kyoto University (Japan), 10. Laboratory of Ultrastructural Virology, Institute for Life and Medical Sciences, Kyoto University (Japan), 11. Department of Genome Informatics, Research Institute for Microbial Diseases, Osaka University (Japan), 12. NGS core facility, Bioinformatics Center, Research Institute for Microbial Diseases, Osaka University (Japan), 13. Department of Pathology, Graduate School of Medicine, Chiba University (Japan))

*Hiroyuki Teruya¹, Toshiyuki Ushijima¹, Manaka Goto^1,2, Hideyuki Takahashi¹, Takahiro Itamiya^1,2, Hirofumi Shoda³, Haruka Tsuchiya¹, Tomohisa Okamura^1,2, Keishi Fujio¹ (1. Department of Allergy and Rheumatology, Graduation School of Medicine, the University of Tokyo (Japan), 2. Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo (Japan), 3. Department of Rheumatology, Tokyo Medical University Hospital (Japan))

*Maya Shofa¹, Emiko Urano¹, Tomotaka Okamura¹, Yasuhiro Yasutomi¹ (1. Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health, and Nutrition (Japan))

*Takuya Hemmi¹, Takao Hashiguchi¹ (1. Institute for Life and Medical Sciences, Kyoto University (Japan))

*MYA MYAT NGWE TUN^1,2,3, Yasuna Nakamura⁴, Chia Hsien Wu⁴, Jean Claude Balingit¹, Ngan Thi Thanh Nguyen ¹, Muhareva Raekiansyah¹, Yuki Takamatsu², Takeshi Urano³, Tsuyoshi Inoue⁴, Kouichi Morita^1,2,3,5 (1. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University (Japan), 2. Department of Virology, Institute of Tropical Medicine, Nagasaki University (Japan), 3. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University (Japan), 4. Department of Physiology of Visceral Function and Body Fluid, Graduate School of Biomedical Sciences, Nagasaki University (Japan), 5. Dejima Infectious Diseases Research Alliance, Nagasaki University (Japan))

*Yuji Kubota¹, Ken J. Ishii², Mutsuhiro Takekawa¹ (1. Division of Cell Signaling and Molecular Medicine, Institute of Medical Science, The University of Tokyo (Japan), 2. Division of Vaccine Science, Institute of Medical Science, The University of Tokyo (Japan))

*Yuichi Koshiishi¹, Marumi Ohno^2,3,4, Masafumi Endo⁵, Kayo Ibaraki⁵, Masashi Shingai^1,2,3,6, Hiroshi Kida^1,2,3,6 (1. Division of Vaccine Immunology, Hokkaido University (Japan), 2. Division of Biologics Development, Hokkaido University (Japan), 3. Institute for Vaccine Research and Development, Hokkaido University (Japan), 4. One Health research center, Hokkaido University (Japan), 5. KM Biologics Co. Ltd. (Japan), 6. International Collaboration Unit, Hokkaido University (Japan))

*Hiroki Hayashi¹, Takashi Matsuzaki², Hironori Nakagami¹ (1. Department of Health Development and Medicine, Osaka University Graduate School of Medicine (Japan), 2. Department of DDS Pharmaceutical Development, Osaka University Graduate School of Medicine (Japan))

*Toshiki Sekiya^1,2,3, Tomomi Kawakita², Mamiko Kawahara¹, Marumi Ohno^1,2,4, Naoki Nomura^1,2, Masashi Shingai^1,2, Hiroshi Kida^1,2 (1. International Institute for Zoonosis Control, Hokkaido University (Japan), 2. Institute for Vaccine Research and Development, Hokkaido Unviersity (Japan), 3. Deapartment of Microbiology and Immunology at Peter Doherty Institute, University of Melbourne (Australia), 4. One Health Research Center, Hokkaido University (Japan))

*Tomomi Kawakita¹, Toshiki Sekiya^1,2, Naoki Nomura², Marumi Ohno^1,2, Chimuka Handabile¹, Hiroshi Kida^1,2, Misako Matsumoto^2,3, Tsukasa Seya^2,3, Masashi Shingai^1,2 (1. Institute for Vaccine Research and Development, Hokkaido University (Japan), 2. International Institute for Zoonosis Control, Hokkaido University (Japan), 3. Nebuta Research Institute for Life Sciences, Aomori University (Japan))

*Atsuko Inoue^1,2, Yukari Itakura¹, Shinji Saito¹, Yasuko Orba^1,3,4, Katsumi Maenaka^1,2,3,5,6, Hirofumi Sawa^1,3,4, Koshiro Tabata¹ (1. Institute for Vaccine Research and Development, Hokkaido University (Japan), 2. Faculty of Pharmaceutical Science, Graduate School of Life Science, Hokkaido University (Japan), 3. International Institute for Zoonosis Control, Hokkaido University (Japan), 4. One Health Research Center, Hokkaido University (Japan), 5. Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University (Japan), 6. Global Station for Biosurfaces and Drug Discovery, Hokkaido University (Japan))

*Shinji Saito¹, Satoshi Osaki¹, Koshiro Tabata¹, Atsuko Inoue¹, Yukari Itakura¹, Gabriel Gonzalez¹, Shinji Watanabe², Hideki Asanuma², Hideki Hasegawa², Hirofumi Sawa¹ (1. Institute for Vaccine Research and Development: HU-IVReD, Hokkaido University (Japan), 2. Research Center for Influenza and Respiratory Viruses, National institute of infectious diseases (Japan))

*Yukari Itakura¹, Koshiro Tabata¹, Shinji Saito¹, Gabriel Gonzalez¹, Hirofumi Sawa^1,2 (1. IVReD, Hokkaido University (Japan), 2. International Institute for Zoonosis Control, Hokkaido University (Japan))

*Sebastian Kapell¹, Shara Bakytbek¹, Farzaneh Valanezhad¹, Ayako Hyuga¹, Shin-Ichi Inoue¹, Katsuyuki Yui¹, Shusaku Mizukami¹, Shinjiro Hamano¹, Matheus Ferraz², Ioannis Vardaxis², Daiki Miura³, Daiki Mori³, Kazuhide Onoguchi³, Kaidre Bendjama¹, Basu Dev Pandey¹, Corazon Cerilla Buerano¹, Trevor Clancy, Satoshi Kaneko¹, Kouichi Morita¹ (1. Nagasaki University (Japan), 2. NEC Oncoimmunity AS (Norway), 3. NEC Corporation (Japan))

Yuying Wang¹, Yuki Kitai¹, Yukiko Akahori¹, Hiroshi Katoh¹, Hideko Watabe¹, Taishi Onodera², Daisuke Kuroda², Ryutaro Kotaki², Ryo Akihide², Katsumi Maenaka⁴, Takao Hashiguchi³, Junki Maruyama⁵, Yoshimasa Takahashi², *Makoto Takeda¹ (1. The University of Tokyo (Japan), 2. National Institute of Infectious Diseases (Japan), 3. Kyoto University (Japan), 4. Hokkaido University (Japan), 5. University of Texas Medical Branch (United States of America))

*Satoshi Taniguchi^1,2, Shigeru Tajima², Ken-Ichi Shibasaki², Masayuki Saijo², Masayuki Shimojima², Chang-Kweng Lim², Meng Ling Moi¹, Hideki Ebihara² (1. Graduate School of Medicine, the University of Tokyo (Japan), 2. National Institute of Infectious Diseases (Japan))

*Naoki Nomura^1,2, Masashi Shingai^1,2, Toshiki Sekiya^1,2, Marumi Ohno^1,2, Chimuka Handabile^1,2, Tomomi Kawakita^1,2, Yuichi Koshiishi¹, Richard Obeng-Kyeremeh¹, Mayako Kawahara¹, Mihoko Ohashi^1,2, Minori Haruta^1,2, Yuki Shimoura¹, Hiroshi Kida^1,2 (1. Hokkaido University International Institute for Zoonosis Control (Japan), 2. Hokkaido University Institute for Vaccine Research and Development (Japan))

*Shuhei Higuchi¹, Hisashi Arase^1,2,3,4 (1. Center for Advanced Modalities and DDS, Osaka University (Japan), 2. Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University (Japan), 3. Laboratory of Immunochemistry, WPI Immunology Frontier Research Center, Osaka University (Japan), 4. Center for Infectious Dissease Education and Research, Osaka University (Japan))

*Chikako Ono^1,2,3, Taro Shimizu⁴, Toshiro Hirai^3,4, Tomoyuki Okuda⁶, Dita Pratama^1,2, Kentaro Uemura^1,2,3, Junki Hirano^1,2, Kazuma Okada^1,2,3, Shuhei Taguwa^1,2,3, Yasuo Yoshioka^1,4,5, Masanao Sato⁷, Yoshiharu Matsuura^1,2,3 (1. Center for Infectious Disease Education and Research (Japan), 2. Research Institute for Microbial Diseases (Japan), 3. Center for Advanced Modalities and DDS (Japan), 4. BIKEN Innovative Vaccine Research Alliance Laboratories (Japan), 5. The Research Foundation for Microbial Diseases (Japan), 6. Faculty of Pharmacy, Meijo University (Japan), 7. Research Faculty of Agriculture, Hokkaido University (Japan))

*Christelle Pemba Mawonga¹, Takaaki Kinoshita¹, Ghislain W.E. Ella², Chimene N. Nkogue², Bernie Bouchedi², Georgelin O. Nguema³, Hayato Ueda¹, Yasuteru Sakurai^1,4, Rokusuke Yoshikawa^1,4, Haruka Abe^1,5, Yuri Ushijima^4,6, Murasaki Amano¹, Etienne F. Akomo-Okoue², Lilian B.M. Koumba², Fred L.M. Nguelet², Pierre P.M. Nguema², Line N. Meyo^1,7, Jiro Yasuda^1,4,7 (1. Department of Emerging Infectious Diseases, National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University (Japan), 2. Institut de Recherche en Ecologie Tropicale (Gabon), 3. Centre de Recherches Médicales de Lambaréné (Gabon), 4. Department of Emerging Infectious Diseases, Institute of Tropical Medicine, Nagasaki University (Japan), 5. Vietnam Research Station, Institute of Tropical Medicine, Nagasaki University (Japan), 6. Division of Biomedical Science, Institute of Medicine, University of Tsukuba (Japan), 7. Graduate School of Biomedical Sciences, Nagasaki University (Japan))

*Linh Bao Nguyen¹, Norikazu Isoda^1,2,3,4, Yik Lim Hew¹, Dang Hoang Nguyen ⁵, Diep Thi Nguyen⁶, Long Van Nguyen⁶, Takahiro Hiono^1,2,3,4, Yoshihiro Sakoda^1,2,3,4 (1. Laboratory of Microbiology, Faculty of Veterinary Medicine, Hokkaido University, Japan (Japan), 2. One Health Research Center, Hokkaido University, Japan (Japan), 3. International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Japan (Japan), 4. Hokkaido University Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Japan (Japan), 5. National Center for Veterinary Diagnosis, Vietnam (Viet Nam), 6. Department of Animal Health, Vietnam (Viet Nam))

*Jean Claude Balingit¹, Motoharu Abe², Ryosuke Suzuki³, Dalouny Xayavong⁴, Mya Myat Ngwe Tun^1,4,5, Mami Matsuda³, Yuki Takamatsu^1,4, Corazon Buerano¹, Kengo Sonoda², Kouichi Morita^1,4,6 (1. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University (Japan), 2. CMC Development Division, KM Biologics Co., Ltd. (Japan), 3. Department of Virology II, National Institute of Infectious Diseases (Japan), 4. Department of Virology, Institute of Tropical Medicine, Nagasaki University (Japan), 5. Center for Vaccine and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University (Japan), 6. DEJIMA Infectious Disease Research Alliance, Nagasaki University (Japan))

*Misao Himeno¹, Ka Ching Wan¹, Ryuichi Majima¹, Satoshi Taniguchi¹, Meng Ling Moi¹ (1. Department of Developmental Medical Scienses, Faculty of Medicine, The University of Tokyo (Japan))

*Hoan T Pham¹, Kohei Yamazaki^2,3, Andreas J. Bäumler³, Toshio Kodama¹, Hirotaka Hiyoshi^1,3 (1. Institute of Tropical Medicine, Nagasaki University (Japan), 2. School of Veterinary Medicine, Kitasato University (Japan), 3. School of Medicine, University of California at Davis (United States of America))

*David Atomanyi Barnes¹, Yuki Ouchi¹, Sasini Jayaweera¹, Pondpan Suwanthada¹, Tamsin Barnes³, Jeewan Thapa¹, Chie Nakajima^1,2, Yasuhiko Suzuki^1,2 (1. Division of Bioresources, Hokkaido University International Institute for Zoonosis Control, Sapporo (Japan), 2. Division of Research Support, Hokkaido University Institute for Vaccine Research and Development, Sapporo (Japan), 3. University of Queensland, School of Veterinary Medicine, Queensland (Australia))

*Tomoyoshi Nozaki¹, Herbert Santos¹ (1. Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo (Japan))

*Naoko Fujita¹, Ryo Komorizono¹, Yuki Furuse¹ (1. Pandemic Preparedness, Infection and Advanced Research Center, The University of Tokyo (Japan))

*Sutthaorn Pothongsrisit¹, Yoji Sagiya¹, Hiromi Tsuru², Chizu Tanikawa¹, Koichi Matsuda^1,2 (1. Laboratory of Clinical Genome Sequencing, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo (Japan), 2. Laboratory of Genome Technology, Human Genome Centre, Institute of Medical Science, University of Tokyo (Japan))

*Yoshifumi Uwamino¹ (1. Keio University School of Medicine (Japan))

*Go Sato^1,2,3, Tomohiro Yata¹, Kotaro Ogawa¹, Tatsuhiko Naito^1,3, Ryuya Edahiro^1,2,3, Kyuto Sonehara^1,3,4, Ryunosuke Saiki⁵, Shinichi Namba^1,3,4, Yuya Shirai^1,3, Kenichi Yamamoto¹, Seishi Ogawa⁵, Hideki Mochizuki¹, Noriko Isobe⁶, Tatsusada Okuno¹, Yukinori Okada^1,2,3,4 (1. Osaka University Graduate School of Medicine (Japan), 2. Center for Advanced Modalities and DDS (CAMaD), Osaka University (Japan), 3. RIKEN Center for Integrative Medical Sciences (Japan), 4. Graduate School of Medicine, the University of Tokyo (Japan), 5. Graduate School of Medicine, Kyoto University (Japan), 6. Graduate School of Medical Sciences, Kyusyu University (Japan))

*Anton Kratz¹ (1. DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University (Japan))

*Kenichi Yamamoto¹, Shinichi Namba^2,1, Kyuto Sonehara^2,1, Ken Suzuki², Niall P Cooke^3,6, Koichi Matsuda², Takashi Gakuhari⁴, Toshimasa Yamauchi², Takashi Kadowaki⁵, Shigeki Nakagome^6,4, Yukinori Okada^1,2,7 (1. Osaka University (Japan), 2. The University of Tokyo (Japan), 3. Max Planck Institute (Germany), 4. Kanazawa University (Japan), 5. Toranomon Hospital (Japan), 6. Trinity college Dublin (Ireland), 7. RIKEN Institute (Japan))

*Akinori Kanai¹, Yukie Kashima¹, Yutaka Suzuki¹ (1. Graduate School of Frontier Sciences, The University of Tokyo (Japan))

*RINTARO FUJIMOTO^1,2, Hiroki Kitaoka^1,3, Saya Hisano^1,2,3, Ryuya Edahiro^1,2, Go Sato^1,2, Akari Suzuki¹, Yukinori Okada^1,2,3, Kazuhiko Yamamoto¹ (1. RIKEN Center for Integrative Medical Sciences (Japan), 2. The University of Osaka (Japan), 3. The University of Tokyo (Japan))

*Norikazu Isoda^1,2,3,4, Takahiro Hiono^1,2,3,4, Yik Lim Hew¹, Daiki Kobayashi¹, Yo Shimazu¹, Nguyen Bao Linh¹, Tatsuru Morita¹, Yoshihiro Sakoda^1,2,3,4 (1. Faculty of Veterinary Medicine, Hokkaido University (Japan), 2. One Health Research Center, Hokkaido University (Japan), 3. International Institute for Zoonosis Control, Hokkaido University (Japan), 4. Hokkaido University Institute for Vaccine Research and Cevelopment (Japan))

*Seitaro Nomura¹, Issei Komuro¹ (1. The University of Tokyo Hospital (Japan))

*Daisuke Akiyama^1,2, Yasuhiro Murakawa^1,3 (1. Institute for the Advanced Study of Human Biology, Kyoto University (Japan), 2. Department of Hematology, Graduate School of Medicine, Kyoto University (Japan), 3. RIKEN-IFOM Joint Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama (Japan))

*Yukie Kashima¹, Yutaka Suzuki¹ (1. Graduate School of Frontier Sciences, The University of Tokyo (Japan))

*Yuji Tsunekawa¹, Jumpei Itho², Takashi Okada¹ (1. Institute of Medical Science, The University of Tokyo DMMG (Japan), 2. Institute of Medical Science, The University of Tokyo DSV (Japan))

*芦田 仁己¹
*Masami Ashida¹, Saya Kuribayashi¹, Yuki Hayashi¹, Yoko Kamada¹, Saori Nomura¹, Jun Takasaki¹, Kiyoshi Takayama¹ (1. NB Health Laboratory (Japan))

*Satoshi Hashimoto¹, Jiahuan ZENG¹, Jennifer SAUERLAND², Toshifumi INADA¹ (1. Division of RNA and Gene Regulation The Institute of Medical Science, The University of Tokyo (Japan), 2. University of Heidelberg (Germany))

*Shunji Suetaka¹ (1. The University of Tokyo (Japan))

*Takanori Asakura^1,2,3, Shuhei Azekawa³, Ho Namkoong⁴, Takashi Yokoyama⁴, Makoto Ishii⁵, Koichi Fukunaga³ (1. Department of Clinical Medicine (Laboratory of Bioregulatory Medicine), Kitasato University School of Pharmacy (Japan), 2. Department of Respiratory Medicine, Kitasato University Kitasato Institute Hospital (Japan), 3. Department of Medicine, Division of Pulmonary Medicine, Keio University School of Medicine (Japan), 4. Department of Infectious Disease, Keio University School of Medicine (Japan), 5. Department of Respiratory Medicine, Nagoya University Graduate School of Medicine (Japan))

*Yoshimi Imawari¹, Sae Aratani¹, Hiroshi Ueki¹, Yoshihiro Kawaoka¹, Makoto Nakanishi¹ (1. Institute of Medical Science, The University of Tokyo (Japan))

*Tomo Nomai¹, Yuki Anraku¹, Shunsuke Kita¹, Hisano Yajima², The G2P-Japan Consortium³, Takao Hashiguchi², Takasuke Fukuhara⁴, Kei Sato⁵, Katsumi Maenaka^1,6,7,8 (1. Faculty of Pharmaceutical Sciences, Hokkaido University (Japan), 2. Institute for Life And Medical Sciences, Kyoto University (Japan), 3. The G2P-Japan Consortium (Japan), 4. Faculty of Medicine, Hokkaido University (Japan), 5. The Institute of Medical Science, The University of Tokyo (Japan), 6. International Institute for Zoonosis Control, Hokkaido University (Japan), 7. Institute for Vaccine Research and Development, Hokkaido University (Japan), 8. Faculty of Pharmaceutical Sciences, Kyushu University (Japan))

*Taiyo Someya¹, Yuki Anraku¹, Shunsuke Kita¹, Taishi Onodera², Takashi Tadokoro³, Takao Hashiguchi⁴, Yoshimasa Takahashi², Katsumi Maenaka¹ (1. Faculty of Pharmaceutical science, Hokkaido University (Japan), 2. Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases (Japan), 3. Graduate School of Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Sanyo-Onoda city university (Japan), 4. Institute for Life and Medical Sciences, Kyoto University (Japan))

*Saori Suzuki^1,2, Rigel Suzuki ^1,2, Shuhei Tsujino¹, Lei Wang³, Hayato Ito¹, Tomokazu Tamura^1,2,4, Naganori Nao^4,5, Keita Matsuno^4,6, Shinya Tanaka³, Takasuke Fukuhara^1,2,4,7,8 (1. Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University (Japan), 2. Institute for Vaccine Research and Development:IVReD, Hokkaido University (Japan), 3. Department of Cancer Pathology, Graduate School of Medicine, Hokkaido University (Japan), 4. One Health Research Center, Hokkaido University (Japan), 5. Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University (Japan), 6. Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University (Japan), 7. Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University (Japan), 8. Department of Virology, Graduate School of Medicine, Kyushu University (Japan))

*Wakako Kumita¹, Natsuki Ooura¹, Erika Sasaki¹ (1. Central Institute for Experimental Medicine and Life Science (Japan))

*Sho Ohta¹, Yasuhiro Yamada¹ (1. Graduate School of Medicine, The University of Tokyo (Japan))

*Yasuhiro Yamada¹ (1. Graduate School of Medicine, The University of Tokyo (Japan))

*Yoshiyuki Manabe^1,2, Keita Ito¹, Shino Ohshima³, Yoshie Kametani³, Kazunori Matsuura⁴, Koichi Fukase^1,2,5 (1. Graduate school of science, Osaka University (Japan), 2. Forefront Research Center, Graduate School of Science, Osaka University (Japan), 3. School of Medicine, Tokai University (Japan), 4. Graduate School of Engineering, Tottori University (Japan), 5. Center for Advanced Modalities and DDS, Osaka University (Japan))

*Shigeru Kawakami¹, Makoto Matsumoto¹, Geng Longjian¹, Mariko Kamiya¹, Kazuya Okami¹, Yoshimasa Tanaka² (1. Graduate School of Biomedical Sciences, Nagasaki University (Japan), 2. Center for Medical Innovation, Nagasaki University (Japan))

*Dorothy DeMore Ellis¹, Jun Seita¹ (1. RIKEN Center for Integrative Medical Sciences (Japan))

Jessica Severin¹, Takahiro Nishino¹, Hiroaki Hatano¹, Yukinori Okada¹, Kazuyoshi Ishigaki¹, *Takeya Kasukawa¹ (1. RIKEN Center for Integrative Medical Sciences (Japan))

*Anusuya Pal¹, Rashmi Rekha Dash², Ryuta Uraki^3,4,5, Cevayir Coban², Yoshihiro Kawaoka^3,4,5,6, Miho Yanagisawa¹ (1. Graduate School of Arts and Sciences, The University of Tokyo (Japan), 2. Division of Malaria Immunology, Department of Microbiology and Immunology, Institute of Medical Science (IMSUT), The University of Tokyo (Japan), 3. The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute (Japan), 4. Division of Virology, Institute of Medical Science, The University of Tokyo (Japan), 5. Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo (Japan), 6. Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison (Japan))

*Izen Ri¹, Kintei Ko², Masahiro Kitao¹, Kyoko Mimura¹, Yusuke Inoue³, Waki Toya⁴, Kaori Muto¹ (1. Department of Public Policy, The Institute of Medical Science, The University of Tokyo (Japan), 2. Graduate School of Interdisciplinary Information Studies, The University of Tokyo (Japan), 3. Department of Healthcare Ethics, School of Public Health, Kyoto University (Japan), 4. Division of Bioethics and Medical Law, The Institute of Medical Science, The University of Tokyo (Japan))

*Yusuke Sato¹, Yuichi Suzuki¹, Mai Yakuwa¹, Hideyoshi Harashima¹ (1. Faculty of Pharmaceutical Sciences, Hokkaido University (Japan))

*Koki Mayusumi¹, Kazuya Kabayama^1,2,3, Kazuko Kaneda-Nakashima^2,3, Kazuhiro Ooe^2,3, Atsushi Toyoshima^2,3, Koichi Fukase^1,2,3 (1. Dept. of Chem., Grad. Sch. of Sci., Osaka Univ. (Japan), 2. FRC, Grad. Sch. of Sci., Osaka Univ. (Japan), 3. Inst. for Radiation Sciences, Osaka Univ. (Japan))

Erik Koehne¹, Michiko Toizumi¹, Hien-Anh Thi Nguyen², Lien Thuy Le³, Kim-Mai Huynh³, Hoang Huy Le², Chihiro Iwasaki ¹, Yutaro Yamagata¹, Hung Thai Do ³, Kouichi Morita⁴, *Laymyint Yoshida¹ (1. Institute of Tropical Medicine, Nagasaki University (Japan), 2. National Institute of Hygiene and Epidemiology (Viet Nam), 3. Pasteur Institute in Nha Trang (Viet Nam), 4. Dejima Infectious Disease Research Alliance, Nagasaki University (Japan))

*Hiroki Tanaka¹, Hidetaka Akita¹ (1. Center for Advanced Modalities and DDS (CAMaD) (Japan))

*Keiichi Motoyama^1,2, Masahiro Ogura², Riru Onigahara², Honami Michiwaki², Toru Taharabaru^1,2, Taishi Higashi^1,2, Shogo Misumi^1,3, Naoki Kishimoto^1,3, Hirotoshi Adachi⁴, Masahiko Kikuchi^1,5 (1. Vaccine Development Research Center, Kumamoto University (Japan), 2. Graduate School of Pharmaceutical Sciences, Kumamoto University (Japan), 3. Depatment of Environmental and Molecular Health Sciences, Kumamoto University (Japan), 4. PassPort Technologies, Inc (United States of America), 5. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (Japan))

*Ryota Sato¹, Kaiwen Liu¹, Takuma Shibata¹, Ryutaro Fukui¹, Kensuke Miyake¹ (1. Division of Innate Immunity, The Institute of Medical Science, The University of Tokyo (Japan))